Concepedia

Marc Cinci

MC

Statistics

Publications

4

Citations

167

H-Index

4

Active since

2013

Affiliations

Heidelberg University(Current)

National Center for Tumor Diseases

University Hospital Heidelberg

Silence Therapeutics (Germany)

Marc Cinci is an author at Heidelberg University specializing in oncology, medicine, and cationic lipoplexes.

Publications per year

2013–2022

4

Publications

4

Lipoplex mediated silencing of membrane regulators (CD46, CD55 and CD59) enhances complement‐dependent anti‐tumor activity of trastuzumab and pertuzumab

Srinivas Mamidi, Marc Cinci, Max Hasmann et al. · Molecular Oncology · 2013 · 110 citations · Full text

, , +17

Bevacizumab-based treatment as salvage therapy in patients with recurrent symptomatic brain metastases

Anna S. Berghoff, Michael O. Breckwoldt, Lars Riedemann et al. · Neuro-Oncology Advances · 2020 · 25 citations · Full text

, , +17

Targeted delivery of siRNA using transferrin-coupled lipoplexes specifically sensitizes CD71 high expressing malignant cells to antibody-mediated complement attack

Marc Cinci, Srinivas Mamidi, Wenhan Li et al. · Targeted Oncology · 2014 · 20 citations

, , +12

Evaluating requests for physician‐assisted suicide. A survey among German oncologists

Jan Schildmann, Marc Cinci, Leonie Kupsch et al. · Cancer Medicine · 2022 · 12 citations · Full text

, , +9

1–4 of 4